Brief: Trinity Biotech appoints Barclays to advise on ongoing strategic realignment process
13/03/2025 11:34
March 13 (Reuters) - Trinity Biotech PLC TRIB.O: TRINITY BIOTECH FURTHER STRENGTHENS FOCUS ON CONTINUOUS GLUCOSE MONITORING – APPOINTS BARCLAYS TO ADVISE ON ONGOING STRATEGIC REALIGNMENT PROCESS TRINITY BIOTECH PLC: DETERMINED THAT CGM TECHNOLOGY AND RELATED DATA DRIVEN INSIGHTS WILL BE CO'S PRIMARY STRATEGIC FOCUS MOVING FORWARD Source text: ID:nGNX2R8H4l Further company coverage: TRIB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Trinity Biotech
See all newsNASDAQ RESUMED AT 12:18 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:13 PM
Brief: Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update
Brief: Trinity Biotech’S Trinovium Subsidiary Agrees To Collaborate With Echelon Data Centres To Develop Advanced Liquid Cooling Solutions For Ai Infrastructure
NASDAQ RESUMED AT 09:00 AM